Literature DB >> 11804995

Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic States: a possible explanation for impaired collateral formation in cardiac tissue.

Eva Chou1, Izumi Suzuma, Kerrie J Way, Darren Opland, Allen C Clermont, Keiko Naruse, Kiyoshi Suzuma, Nancy L Bowling, Chris J Vlahos, Lloyd Paul Aiello, George L King.   

Abstract

BACKGROUND: Inadequate angiogenic response to ischemia in the myocardium of diabetic patients could result in poor collateral formation. Yet, excessive neovascularization in the retina causes proliferative diabetic retinopathy. Since vascular endothelial growth factor (VEGF) is the major angiogenic factor expressed in response to hypoxia, we have characterized expression of VEGF and its receptors in retina, renal glomeruli, aorta, and myocardium in insulin-resistant and diabetic states. Methods and Results- The expression of mRNA and protein for VEGF and its receptors, VEGF-R1 and VEGF-R2, in the myocardium was decreased significantly by 40% to 70% in both diabetic and insulin-resistant nondiabetic rats. Twofold reductions in VEGF and VEGF-R2 were observed in ventricles from diabetic patients compared with nondiabetic donors. In contrast, expression of VEGF and its receptors were increased 2-fold in retina and glomeruli from diabetic or insulin-resistant rats. Insulin treatment of diabetic rats normalized changes in both cardiac and microvascular tissues. Insulin increased VEGF mRNA expression in cultured rat neonatal cardiac myocytes.
CONCLUSIONS: The results documented for the first time that differential regulation of VEGF and its receptors exist between microvascular and cardiac tissues, which can be regulated by insulin. These results provide a potential explanation for concomitant capillary leakage and neovascularization in the retina and inadequate collateral formation in the myocardium of insulin-resistant and diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11804995     DOI: 10.1161/hc0302.102143

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  110 in total

1.  Serum adiponectin and leptin in relation to risk for preeclampsia: results from a large case-control study.

Authors:  Maria Dalamaga; Sindhu K Srinivas; Michal A Elovitz; John Chamberland; Christos S Mantzoros
Journal:  Metabolism       Date:  2011-05-31       Impact factor: 8.694

2.  Diabetes: Podocytes lose their footing.

Authors:  Christian Rask-Madsen; George L King
Journal:  Nature       Date:  2010-11-04       Impact factor: 49.962

3.  More sugar, less blood vessels: another piece in the puzzle of increased cardiovascular risk in diabetes.

Authors:  Christian Rask-Madsen; George L King
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-04       Impact factor: 8.311

4.  A ligand-independent VEGFR2 signaling pathway limits angiogenic responses in diabetes.

Authors:  Carmen M Warren; Safiyyah Ziyad; Anaïs Briot; Aaron Der; M Luisa Iruela-Arispe
Journal:  Sci Signal       Date:  2014-01-07       Impact factor: 8.192

Review 5.  Activation of protein kinase C isoforms and its impact on diabetic complications.

Authors:  Pedro Geraldes; George L King
Journal:  Circ Res       Date:  2010-04-30       Impact factor: 17.367

6.  Asperosaponin VI promotes angiogenesis and accelerates wound healing in rats via up-regulating HIF-1α/VEGF signaling.

Authors:  Cheng-Gui Wang; Yi-Ting Lou; Min-Ji Tong; Li-Lian Zhang; Zeng-Jie Zhang; Yong-Zeng Feng; Shi Li; Hua-Zi Xu; Cong Mao
Journal:  Acta Pharmacol Sin       Date:  2017-12-07       Impact factor: 6.150

Review 7.  Role of microangiopathy in diabetic cardiomyopathy.

Authors:  Adriana Adameova; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

8.  Abnormal angiogenesis in diabetic nephropathy.

Authors:  Takahiko Nakagawa; Tomoki Kosugi; Masakazu Haneda; Christopher J Rivard; David A Long
Journal:  Diabetes       Date:  2009-07       Impact factor: 9.461

9.  Coadministration of adenoviral vascular endothelial growth factor and angiopoietin-1 enhances vascularization and reduces ventricular remodeling in the infarcted myocardium of type 1 diabetic rats.

Authors:  Samson Mathews Samuel; Yuzo Akita; Debayon Paul; Mahesh Thirunavukkarasu; Lijun Zhan; Perumana R Sudhakaran; Chuanfu Li; Nilanjana Maulik
Journal:  Diabetes       Date:  2009-09-30       Impact factor: 9.461

Review 10.  Diabetic cardiomyopathy.

Authors:  Omar Asghar; Ahmed Al-Sunni; Kaivan Khavandi; Ali Khavandi; Sarah Withers; Adam Greenstein; Anthony M Heagerty; Rayaz A Malik
Journal:  Clin Sci (Lond)       Date:  2009-05       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.